Oncology Nursing

Oncology nursing focuses on the prevention, early detection, diagnosis, treatment, symptom management, and supportive care of patients with cancer and hematologic malignancies. Because cancer involves uncontrolled abnormal cell growth that may invade surrounding tissues and metastasize to distant organs, early recognition and multidisciplinary treatment are essential to improve survival and quality of life. Nurses play a major role in cancer screening, chemotherapy administration, radiation safety, surgical care, oncologic emergency recognition, pain management, infection prevention, psychosocial support, palliative care, and patient education. Effective oncology nursing integrates pathophysiology, diagnostic interpretation, pharmacologic therapy, surgical and radiation management, immunotherapy, symptom control, rehabilitation, and holistic interdisciplinary care.

1️⃣ 🎗️ Cancer Pathophysiology & Carcinogenesis

🧬 Pathophysiology & Risk Factors

🔷 Normal cells mutate → uncontrolled abnormal proliferation

🔷 Carcinogenesis stages: initiation, promotion, progression

🔷 DNA damage may activate oncogenes / silence suppressors

🔷 Risk factors: smoking, radiation, viruses, chemicals

🔷 Chronic inflammation ↑ mutation and malignancy risk

🔷 Metastasis spreads through blood, lymph, direct invasion

🔎 Clinical Manifestations & Diagnostics

🔷 CAUTION signs: change, sore, bleeding, lump

🔷 Unexplained weight loss, fatigue, persistent pain

🔷 Imaging: CT, MRI, PET, ultrasound staging

🔷 Biopsy confirms malignancy and histologic type

🔷 Tumor markers support monitoring, not always diagnosis

🔷 Pathology identifies grade, margins, receptor status

💊 Medical / Surgical Management

🔷 Surgery removes localized tumor when operable

🔷 Chemotherapy targets rapidly dividing malignant cells

🔷 Radiation damages tumor DNA locally

🔷 Immunotherapy activates immune recognition of cancer

🔷 Targeted therapy blocks specific mutation pathways

🔷 Palliative care controls symptoms at any stage

🩺 Nursing & Collaborative Management

🔷 Assess symptoms, risk factors, family history

🔷 Support screening and early detection adherence

🔷 Monitor treatment response and adverse effects

🔷 Educate warning signs needing urgent consult

🔷 Provide psychosocial support after diagnosis

🔷 Collaborate oncology, surgery, radiation, palliative teams

2️⃣ 🎗️ Cancer Risk Factors

🧬 Pathophysiology & Risk Factors

🔷 Tobacco exposure strongly linked lung, oral, bladder cancer

🔷 Alcohol ↑ liver, esophageal, breast cancer risk

🔷 UV radiation damages skin cell DNA

🔷 HPV, HBV, HCV, EBV linked cancers

🔷 Obesity increases estrogen/inflammation-related cancers

🔷 Family history suggests inherited mutation risk

🔎 Assessment & Diagnostics

🔷 Assess lifestyle: smoking, alcohol, diet, activity

🔷 Ask occupational exposure: asbestos, benzene, radiation

🔷 Review infection history HPV / HBV / HCV

🔷 Identify red flags: bleeding, lump, weight loss

🔷 Genetic testing if strong family pattern

🔷 Screening based on age, sex, risk profile

💊 Prevention / Medical Management

🔷 Smoking cessation reduces multiple cancer risks

🔷 HPV vaccine prevents cervical and related cancers

🔷 HBV vaccine prevents hepatitis B–related liver cancer

🔷 Sunscreen and protective clothing reduce melanoma risk

🔷 Weight control and exercise lower cancer burden

🔷 Treat premalignant lesions before progression

🩺 Nursing & Collaborative Management

🔷 Provide nonjudgmental lifestyle risk counseling

🔷 Encourage vaccination and screening completion

🔷 Teach self-awareness for unusual body changes

🔷 Refer genetic counseling when indicated

🔷 Promote healthy diet, fiber, fruits, vegetables

🔷 Coordinate community cancer prevention education

3️⃣ 🎗️ Cancer Prevention: Primary, Secondary, Tertiary

🧬 Core Concepts & Risk Factors

🔷 Primary prevention stops cancer before development

🔷 Secondary prevention detects early / precancerous disease

🔷 Tertiary prevention reduces complications and recurrence

🔷 High-risk groups need earlier focused screening

🔷 Prevention depends on behavior + system access

🔷 Delayed screening increases advanced-stage diagnosis

🔎 Assessment & Screening

🔷 Assess vaccine status HPV and hepatitis B

🔷 Check tobacco, alcohol, occupational exposure history

🔷 Review Pap smear, mammogram, colonoscopy adherence

🔷 Identify family history of early cancers

🔷 Monitor survivors for recurrence warning signs

🔷 Evaluate barriers: cost, fear, transport, stigma

💊 Prevention / Medical Management

🔷 Primary: vaccination, smoking cessation, sun protection

🔷 Secondary: Pap smear, mammogram, colonoscopy, FOBT

🔷 Tertiary: rehabilitation, surveillance, recurrence prevention

🔷 Chemoprevention possible high-risk breast cancer patients

🔷 Treat H. pylori ↓ gastric cancer risk

🔷 Antiviral therapy reduces HBV/HCV liver cancer risk

🩺 Nursing & Collaborative Management

🔷 Educate prevention using simple risk language

🔷 Encourage screening according to eligibility

🔷 Address myths and fear about cancer tests

🔷 Support follow-up after abnormal results

🔷 Teach survivorship care and recurrence monitoring

🔷 Collaborate primary care and public health programs

4️⃣ 🎗️ Cancer Screening & Early Detection

🧬 Core Concepts & Risk Factors

🔷 Screening detects cancer before symptoms appear

🔷 Early-stage detection improves treatment outcomes

🔷 Screening choice depends on risk and age

🔷 False positives may cause anxiety/overtesting

🔷 False negatives require symptom vigilance still

🔷 High-risk patients may need earlier screening

🔎 Screening & Diagnostics

🔷 Breast: mammography detects early breast lesions

🔷 Cervical: Pap smear + HPV testing

🔷 Colorectal: colonoscopy, FIT/FOBT stool testing

🔷 Lung: low-dose CT for high-risk smokers

🔷 Prostate: PSA + DRE individualized decision

🔷 Liver: ultrasound + AFP for high-risk cirrhosis/HBV

💊 Medical / Diagnostic Management

🔷 Abnormal screening requires diagnostic confirmation

🔷 Biopsy confirms malignancy and tumor type

🔷 Endoscopy evaluates GI suspicious lesions

🔷 Imaging stages local and distant spread

🔷 Tumor markers monitor selected cancers

🔷 Genetic testing guides high-risk surveillance

🩺 Nursing & Collaborative Management

🔷 Teach screening purpose, procedure, preparation

🔷 Reduce anxiety through clear instructions

🔷 Track follow-up after abnormal results

🔷 Promote culturally sensitive screening education

🔷 Encourage family risk communication when appropriate

🔷 Coordinate referrals for diagnostics and oncology care

5️⃣ 🎗️ Benign vs Malignant Tumors

🧬 Pathophysiology & Risk Factors

🔷 Benign tumors grow slowly, localized, noninvasive

🔷 Malignant tumors invade tissue and metastasize

🔷 Benign cells usually well-differentiated

🔷 Malignant cells often poorly differentiated/anaplastic

🔷 Encapsulation common in benign masses

🔷 Necrosis/angiogenesis common in aggressive malignancy

🔎 Clinical Manifestations & Diagnostics

🔷 Benign masses often mobile and well-defined

🔷 Malignant masses may be hard, fixed, irregular

🔷 Rapid growth raises suspicion for malignancy

🔷 Imaging describes size, borders, invasion pattern

🔷 Biopsy distinguishes benign from malignant

🔷 Histology shows differentiation, mitoses, invasion

💊 Medical / Surgical Management

🔷 Benign tumors observed if asymptomatic/stable

🔷 Surgical excision if compressive or symptomatic

🔷 Malignant tumors need staging before treatment

🔷 Cancer treatment may combine surgery, chemo, radiation

🔷 Margins checked after tumor excision

🔷 Follow-up monitors recurrence or progression

🩺 Nursing & Collaborative Management

🔷 Avoid reassuring “benign” before biopsy confirmation

🔷 Teach warning signs: growth, bleeding, pain

🔷 Support patient during diagnostic waiting period

🔷 Monitor post-biopsy bleeding and infection

🔷 Educate follow-up even after benign result

🔷 Collaborate pathology/surgery/oncology as needed

6️⃣ 🎗️ Cancer Staging & Grading

🧬 Pathophysiology & Core Concepts

🔷 Staging describes cancer extent/spread

🔷 Grading describes abnormality/aggressiveness of cells

🔷 TNM = tumor, nodes, metastasis

🔷 Higher stage usually indicates wider spread

🔷 Higher grade usually indicates faster growth

🔷 Stage guides treatment plan and prognosis

🔎 Diagnostics & Interpretation

🔷 T assesses primary tumor size/invasion

🔷 N assesses regional lymph node involvement

🔷 M assesses distant metastasis presence

🔷 CT/MRI/PET evaluate tumor spread

🔷 Biopsy determines histologic grade

🔷 Sentinel lymph node biopsy checks early spread

💊 Medical / Treatment Planning

🔷 Early stage often managed surgically

🔷 Locally advanced disease may need combined therapy

🔷 Metastatic disease often needs systemic treatment

🔷 Radiation targets localized tumor burden

🔷 Chemotherapy treats systemic microscopic disease

🔷 Palliative care appropriate at any stage

🩺 Nursing & Collaborative Management

🔷 Explain staging without giving false reassurance

🔷 Clarify difference between stage and grade

🔷 Support patient after new diagnosis/staging results

🔷 Coordinate imaging, biopsy, oncology referrals

🔷 Reinforce treatment plan based on staging

🔷 Assess anxiety, coping, family understanding

7️⃣ 🎗️ Tumor Markers & Diagnostic Tests

🧬 Pathophysiology & Core Concepts

🔷 Tumor markers may reflect cancer activity

🔷 Some markers produced by tumor cells

🔷 Others reflect body response to tumor

🔷 Markers not always diagnostic alone

🔷 Levels may rise in benign conditions

🔷 Trends often more useful than single value

🔎 Common Markers & Diagnostics

🔷 AFP ↑ liver cancer, germ cell tumors

🔷 PSA ↑ prostate cancer or BPH

🔷 CA-125 ↑ ovarian cancer monitoring

🔷 CEA ↑ colorectal cancer monitoring

🔷 CA 19-9 ↑ pancreatic/biliary cancers

🔷 β-hCG ↑ testicular/germ cell tumors

💊 Medical / Diagnostic Management

🔷 Use markers with imaging and biopsy

🔷 Serial levels monitor treatment response

🔷 Rising markers may suggest recurrence

🔷 Normal marker does not exclude cancer

🔷 Biopsy remains definitive diagnosis method

🔷 Imaging locates tumor/metastatic disease

🩺 Nursing & Collaborative Management

🔷 Teach markers are supportive, not absolute

🔷 Prepare patient for blood tests/imaging

🔷 Reduce anxiety about mildly elevated results

🔷 Track trends across treatment cycles

🔷 Encourage follow-up for abnormal findings

🔷 Collaborate oncology, pathology, radiology teams

8️⃣ 🎗️ Biopsy, Imaging, and Histopathology

🧬 Pathophysiology & Core Concepts

🔷 Biopsy confirms cancer cellular diagnosis

🔷 Histopathology identifies tumor type/origin

🔷 Imaging assesses size, location, spread

🔷 Cytology evaluates individual abnormal cells

🔷 Margins show completeness of tumor removal

🔷 Receptor testing guides targeted therapy

🔎 Diagnostic Modalities

🔷 Fine-needle aspiration samples cells

🔷 Core biopsy obtains tissue architecture

🔷 Excisional biopsy removes entire lesion

🔷 CT/MRI define local invasion

🔷 PET detects metabolically active metastases

🔷 Endoscopy visualizes internal mucosal tumors

💊 Medical / Procedural Management

🔷 Local anesthesia used for minor biopsy

🔷 Sedation may be needed endoscopic biopsy

🔷 Contrast imaging requires renal function check

🔷 Hold anticoagulants when ordered before biopsy

🔷 Pathology report guides definitive treatment

🔷 Molecular testing identifies actionable mutations

🩺 Nursing & Collaborative Management

🔷 Verify consent before invasive biopsy

🔷 Check bleeding risk, INR/platelets

🔷 Monitor biopsy site bleeding/swelling

🔷 Teach post-procedure activity restrictions

🔷 Report fever, drainage, severe pain

🔷 Coordinate results follow-up and counseling

9️⃣ 🎗️ Chemotherapy Principles

🧬 Pathophysiology & Core Concepts

🔷 Chemotherapy targets rapidly dividing cells

🔷 Affects cancer cells and normal fast-dividing tissues

🔷 Cell-cycle specific drugs act during phases

🔷 Combination therapy reduces resistance risk

🔷 Dose intensity influences tumor response

🔷 Toxicity limits treatment dosing/schedule

🔎 Assessment & Monitoring

🔷 Check CBC before each cycle

🔷 ANC <500/mm³ = severe neutropenia

🔷 Platelets <50,000/mm³ ↑ bleeding risk

🔷 Monitor creatinine for renal clearance

🔷 Monitor AST/ALT for hepatic metabolism

🔷 Assess nausea, mucositis, fatigue, neuropathy

💊 Medical / Pharmacologic Management

🔷 Alkylators: cyclophosphamide damages DNA

🔷 Antimetabolites: methotrexate inhibits DNA synthesis

🔷 Anthracyclines: doxorubicin cardiotoxic risk

🔷 Taxanes: paclitaxel disrupts microtubules

🔷 Platinum agents: cisplatin crosslinks DNA

🔷 Antiemetics: ondansetron, aprepitant, dexamethasone

🩺 Nursing & Collaborative Management

🔷 Verify patient, drug, dose, route, protocol

🔷 Use chemotherapy PPE and safe handling

🔷 Monitor extravasation, stop infusion if suspected

🔷 Educate infection and bleeding precautions

🔷 Encourage hydration and oral care

🔷 Coordinate oncology pharmacist and provider review

🔟 🎗️ Chemotherapy Side Effects & Nursing Care

🧬 Pathophysiology & Risk Factors

🔷 Bone marrow suppression causes pancytopenia

🔷 GI mucosal injury causes nausea/mucositis

🔷 Hair follicles affected → alopecia

🔷 Peripheral nerves damaged by neurotoxic agents

🔷 Cardiac toxicity possible with anthracyclines

🔷 Renal toxicity possible with cisplatin

🔎 Clinical Manifestations & Diagnostics

🔷 Neutropenia → fever may be only sign

🔷 Anemia → fatigue, pallor, dyspnea

🔷 Thrombocytopenia → petechiae, bruising, bleeding

🔷 Mucositis → painful ulcers, poor intake

🔷 Neuropathy → numbness, tingling, gait issues

🔷 Monitor CBC, creatinine, liver enzymes

💊 Medical / Supportive Management

🔷 Filgrastim stimulates neutrophil recovery

🔷 Ondansetron controls nausea/vomiting

🔷 Epoetin alfa selected anemia management

🔷 Platelet transfusion severe thrombocytopenia/bleeding

🔷 Loperamide treats chemotherapy-related diarrhea

🔷 Dexrazoxane reduces doxorubicin cardiotoxicity risk

🩺 Nursing & Collaborative Management

🔷 Report fever ≥38°C urgently

🔷 Avoid crowds and sick contacts

🔷 Use soft toothbrush, electric razor

🔷 Encourage small frequent meals

🔷 Provide saline mouth rinses regularly

🔷 Monitor psychosocial distress and body image

1️⃣1️⃣ 🎗️ Radiation Therapy Principles

🧬 Pathophysiology & Core Concepts

🔷 Radiation damages cancer-cell DNA replication

🔷 Rapidly dividing cells more radiosensitive

🔷 External beam most common radiation method

🔷 Brachytherapy places source near tumor site

🔷 Radiation may be curative, adjuvant, palliative

🔷 Surrounding normal tissue may also be affected

🔎 Assessment & Diagnostics

🔷 CT simulation maps precise treatment field

🔷 Skin markings guide accurate positioning daily

🔷 Monitor CBC if large marrow areas irradiated

🔷 Assess mucositis, dermatitis, fatigue regularly

🔷 Imaging evaluates tumor response after therapy

🔷 Organ-specific toxicity depends treatment location

💊 Medical / Radiation Management

🔷 Fractionation divides doses to reduce toxicity

🔷 IMRT improves targeted tumor delivery precision

🔷 Radiosensitizers may enhance radiation effectiveness

🔷 Analgesics manage pain/inflammatory side effects

🔷 Antiemetics useful abdominal/pelvic radiation nausea

🔷 Steroids reduce edema around irradiated tumors

🩺 Nursing & Collaborative Management

🔷 Do not remove radiation skin markings

🔷 Avoid lotions/perfumes unless approved

🔷 Protect irradiated skin from sunlight

🔷 Encourage rest for radiation fatigue

🔷 Monitor swallowing difficulty oral/throat radiation

🔷 Reinforce treatment schedule adherence importance

1️⃣2️⃣ 🎗️ Radiation Side Effects & Safety

🧬 Pathophysiology & Risk Factors

🔷 Radiation injures both malignant and normal cells

🔷 Side effects depend dose and body area

🔷 Rapidly dividing tissues most affected severely

🔷 Bone marrow suppression possible extensive irradiation

🔷 Fibrosis may occur long-term after treatment

🔷 Internal radiation may emit temporary radioactivity

🔎 Clinical Manifestations & Diagnostics

🔷 Radiation dermatitis: erythema, peeling, ulceration

🔷 Oral mucositis common head-neck radiation

🔷 Diarrhea may occur pelvic/abdominal radiation

🔷 Fatigue very common cumulative symptom

🔷 CBC may show anemia/leukopenia

🔷 Pulmonary fibrosis possible chest irradiation complication

💊 Medical / Supportive Management

🔷 Topical creams reduce skin irritation

🔷 Saline/bicarbonate rinses relieve mucositis discomfort

🔷 Antidiarrheals manage radiation enteritis symptoms

🔷 Nutritional supplementation supports healing needs

🔷 Analgesics treat painful inflammatory reactions

🔷 Time-distance-shielding principles for radiation safety

🩺 Nursing & Collaborative Management

🔷 Wear dosimeter if working radiation areas

🔷 Limit exposure time around brachytherapy sources

🔷 Monitor skin integrity and infection signs

🔷 Encourage high-protein high-calorie nutrition

🔷 Teach oral care during head-neck radiation

🔷 Reinforce visitor restrictions if radioactive implants present

1️⃣3️⃣ 🎗️ Cancer Surgery Principles

🧬 Pathophysiology & Core Concepts

🔷 Surgery may diagnose, stage, cure, palliate cancer

🔷 Curative surgery removes localized malignant tissue

🔷 Debulking decreases tumor burden before adjunct therapy

🔷 Palliative surgery relieves obstruction or pain

🔷 Lymph node removal assesses metastatic spread

🔷 Surgical stress may impair immunity temporarily

🔎 Assessment & Diagnostics

🔷 Pre-op imaging defines tumor extent

🔷 Biopsy confirms malignancy before major surgery

🔷 CBC, coagulation, renal function assessed pre-op

🔷 Nutritional status affects wound healing outcomes

🔷 Post-op monitor bleeding, infection, organ function

🔷 Pathology margins determine residual disease risk

💊 Medical / Surgical Management

🔷 Prophylactic antibiotics reduce surgical infection risk

🔷 Analgesics support postoperative pain control

🔷 Drains may remove excess fluid accumulation

🔷 Adjuvant chemo/radiation possible after surgery

🔷 Reconstructive procedures improve body function/image

🔷 ERAS protocols improve recovery and mobility

🩺 Nursing & Collaborative Management

🔷 Reinforce pre-op teaching and consent verification

🔷 Encourage incentive spirometry and ambulation early

🔷 Monitor incision, drains, bleeding closely

🔷 Manage pain while promoting mobility

🔷 Support body-image and emotional adaptation

🔷 Coordinate surgery, oncology, rehab follow-up care

1️⃣4️⃣ 🎗️ Immunotherapy & Targeted Therapy

🧬 Pathophysiology & Core Concepts

🔷 Immunotherapy enhances immune destruction of cancer

🔷 Checkpoint inhibitors block tumor immune evasion

🔷 Targeted therapy attacks specific molecular mutations

🔷 HER2, EGFR, BCR-ABL common targets

🔷 Less generalized toxicity than traditional chemotherapy

🔷 Immune activation may damage healthy tissues

🔎 Clinical Manifestations & Diagnostics

🔷 Rash, diarrhea, hepatitis possible immune toxicity

🔷 Pneumonitis may cause cough/dyspnea

🔷 Endocrine dysfunction possible thyroid/adrenal involvement

🔷 Molecular testing identifies targetable mutations

🔷 CBC, liver enzymes monitor treatment toxicity

🔷 Imaging tracks tumor response progression

💊 Medical / Pharmacologic Management

🔷 Pembrolizumab, nivolumab checkpoint inhibitors

🔷 Trastuzumab targets HER2-positive breast cancer

🔷 Imatinib inhibits BCR-ABL in CML

🔷 Osimertinib targets EGFR-mutated lung cancer

🔷 Corticosteroids treat severe immune-related reactions

🔷 Therapy held if severe organ toxicity develops

🩺 Nursing & Collaborative Management

🔷 Monitor new cough, diarrhea, rash promptly

🔷 Assess endocrine symptoms fatigue/hypotension changes

🔷 Educate delayed immune reactions possible

🔷 Reinforce adherence oral targeted therapies

🔷 Monitor infusion reactions during administration

🔷 Coordinate oncology/pharmacy/lab monitoring schedules

1️⃣5️⃣ 🎗️ Hormonal Therapy in Cancer

🧬 Pathophysiology & Risk Factors

🔷 Some cancers depend on hormones for growth

🔷 Breast cancer may be estrogen/progesterone receptor positive

🔷 Prostate cancer growth stimulated by testosterone

🔷 Hormonal therapy blocks hormone production/action

🔷 Long-term therapy often needed recurrence prevention

🔷 Endocrine side effects common during treatment

🔎 Clinical Manifestations & Diagnostics

🔷 ER/PR testing guides breast cancer therapy

🔷 PSA monitors prostate cancer response

🔷 Hot flashes common hormonal therapy effect

🔷 Osteoporosis risk increases with hormone suppression

🔷 Fatigue, mood changes may occur

🔷 Bone density monitoring important long-term therapy

💊 Medical / Pharmacologic Management

🔷 Tamoxifen blocks estrogen breast tissue receptors

🔷 Aromatase inhibitors: anastrozole, letrozole reduce estrogen

🔷 Leuprolide suppresses testosterone production prostate cancer

🔷 Antiandrogens: bicalutamide block androgen receptors

🔷 Calcium/vitamin D reduce bone loss risk

🔷 Bisphosphonates may prevent therapy-induced osteoporosis

🩺 Nursing & Collaborative Management

🔷 Educate adherence despite delayed benefits

🔷 Monitor DVT risk tamoxifen therapy

🔷 Encourage weight-bearing exercise and calcium intake

🔷 Assess mood, sexual dysfunction, body-image concerns

🔷 Monitor bone pain and fracture risk

🔷 Reinforce regular oncology and lab follow-up

1️⃣6️⃣ 🎗️ Palliative Care & Cancer Pain Management

🧬 Pathophysiology & Core Concepts

🔷 Cancer pain may be nociceptive, neuropathic, visceral

🔷 Tumor invasion compresses nerves, bone, organs

🔷 Palliative care improves comfort at any stage

🔷 Goals include symptom control, dignity, function

🔷 Advanced cancer may cause total pain experience

🔷 Psychosocial distress can intensify pain perception

🔎 Assessment & Diagnostics

🔷 Use PQRST and 0–10 pain scale

🔷 Identify baseline pain vs breakthrough pain

🔷 Assess function, sleep, appetite, mood

🔷 Monitor sedation, constipation, respiratory depression

🔷 Imaging may identify bone metastasis/compression

🔷 Evaluate spiritual, family, cultural concerns

💊 Medical / Supportive Management

🔷 Morphine controls moderate-severe cancer pain

🔷 Fentanyl useful transdermal or rapid breakthrough forms

🔷 Oxycodone oral option for persistent pain

🔷 Gabapentin treats neuropathic pain component

🔷 Bisphosphonates reduce bone metastasis pain

🔷 Laxatives prevent opioid-induced constipation

🩺 Nursing & Collaborative Management

🔷 Reassess pain after every intervention

🔷 Educate around-the-clock dosing vs PRN

🔷 Monitor opioid side effects and safety

🔷 Support advance care planning discussions

🔷 Provide family teaching for home comfort

🔷 Collaborate palliative care/hospice team

1️⃣7️⃣ 🎗️ Cancer-Related Fatigue, Cachexia, Nutrition

🧬 Pathophysiology & Risk Factors

🔷 Cancer cachexia causes muscle wasting and weight loss

🔷 Inflammation increases metabolic demand and catabolism

🔷 Chemotherapy/radiation may reduce appetite intake

🔷 Tumors may alter taste, swallowing, digestion

🔷 Anemia worsens fatigue and exercise intolerance

🔷 Depression/sleep disturbance intensify fatigue perception

🔎 Clinical Manifestations & Diagnostics

🔷 Unintentional weight loss common warning sign

🔷 Early satiety, anorexia, taste changes occur

🔷 Weakness limits activity and self-care

🔷 Albumin/prealbumin may reflect nutritional depletion

🔷 CBC evaluates anemia contributing fatigue

🔷 Monitor BMI, intake records, muscle wasting

💊 Medical / Supportive Management

🔷 High-calorie high-protein diet encouraged

🔷 Megestrol acetate may stimulate appetite

🔷 Ondansetron controls nausea limiting intake

🔷 Treat anemia with transfusion or epoetin alfa selectively

🔷 Enteral feeding if GI tract functional

🔷 TPN reserved when enteral feeding impossible

🩺 Nursing & Collaborative Management

🔷 Offer small frequent nutrient-dense meals

🔷 Manage mouth sores before eating

🔷 Encourage energy conservation and planned rest

🔷 Monitor daily intake and weekly weight

🔷 Reduce food odors causing nausea

🔷 Collaborate dietitian and oncology team

1️⃣8️⃣ 🎗️ Neutropenia & Infection Prevention

🧬 Pathophysiology & Risk Factors

🔷 Chemotherapy suppresses bone marrow neutrophil production

🔷 ANC <1,500/mm³ indicates neutropenia

🔷 ANC <500/mm³ = severe infection risk

🔷 Fever may be only infection sign

🔷 Mucosal injury allows bacterial entry

🔷 Central lines increase bloodstream infection risk

🔎 Clinical Manifestations & Diagnostics

🔷 Fever ≥38°C is oncologic emergency

🔷 Chills, malaise, hypotension suggest sepsis

🔷 WBC/ANC monitored before chemotherapy cycles

🔷 Blood cultures from line/peripheral sites

🔷 Chest x-ray if respiratory symptoms present

🔷 Urine culture if dysuria or fever source

💊 Medical / Supportive Management

🔷 Cefepime empiric febrile neutropenia therapy

🔷 Piperacillin/tazobactam alternative broad coverage

🔷 Vancomycin added if line infection/MRSA concern

🔷 Filgrastim stimulates neutrophil recovery

🔷 Antifungals if prolonged fever/neutropenia persists

🔷 Antivirals if HSV/VZV risk present

🩺 Nursing & Collaborative Management

🔷 Implement neutropenic precautions strictly

🔷 Avoid fresh flowers, raw foods, sick visitors

🔷 Perform meticulous hand hygiene and oral care

🔷 Monitor temperature every 4 hours

🔷 Report fever immediately, do not delay

🔷 Maintain central-line asepsis carefully

1️⃣9️⃣ 🎗️ Bleeding Risk, Anemia, Thrombocytopenia

🧬 Pathophysiology & Risk Factors

🔷 Bone marrow suppression reduces RBCs/platelets

🔷 Tumor invasion may impair marrow production

🔷 Platelets <50,000/mm³ increases bleeding risk

🔷 Platelets <20,000/mm³ severe spontaneous bleeding risk

🔷 Anemia decreases oxygen-carrying capacity

🔷 DIC may occur in advanced malignancy

🔎 Clinical Manifestations & Diagnostics

🔷 Anemia: fatigue, pallor, dyspnea, tachycardia

🔷 Thrombocytopenia: petechiae, bruising, epistaxis

🔷 Melena/hematuria suggest internal bleeding

🔷 CBC tracks hemoglobin and platelet trends

🔷 PT/INR, aPTT assess coagulation status

🔷 Stool occult blood detects GI bleeding

💊 Medical / Supportive Management

🔷 PRBC transfusion for symptomatic severe anemia

🔷 Platelet transfusion for severe thrombocytopenia/bleeding

🔷 Epoetin alfa selected chemotherapy-related anemia

🔷 Iron, folate, B12 if deficient

🔷 Hold anticoagulants if bleeding risk severe

🔷 Treat underlying marrow disease or bleeding source

🩺 Nursing & Collaborative Management

🔷 Use soft toothbrush and electric razor

🔷 Avoid IM injections and rectal temperatures

🔷 Apply pressure longer after venipuncture

🔷 Monitor stools, urine, gums, skin

🔷 Implement fall precautions during anemia/weakness

🔷 Educate report headache or sudden bleeding

2️⃣0️⃣ 🎗️ Oncologic Emergencies Overview

🧬 Pathophysiology & Risk Factors

🔷 Emergencies result from tumor burden or therapy

🔷 Rapid recognition prevents organ failure/death

🔷 TLS occurs after massive tumor cell lysis

🔷 Spinal cord compression threatens permanent paralysis

🔷 SVCS impairs venous return from upper body

🔷 Hypercalcemia causes neurologic/cardiac instability

🔎 Clinical Manifestations & Diagnostics

🔷 TLS: K⁺ ↑, phosphate ↑, calcium ↓, uric acid ↑

🔷 Cord compression: back pain, weakness, bladder dysfunction

🔷 SVCS: facial swelling, JVD, dyspnea

🔷 Hypercalcemia: confusion, constipation, polyuria

🔷 Febrile neutropenia: fever ≥38°C + low ANC

🔷 Imaging/labs confirm emergency type quickly

💊 Medical / Emergency Management

🔷 TLS: IV fluids, allopurinol, rasburicase

🔷 Cord compression: dexamethasone, radiation/surgery

🔷 SVCS: oxygen, steroids, radiation/stent

🔷 Hypercalcemia: IV saline, calcitonin, bisphosphonates

🔷 Febrile neutropenia: cefepime or piperacillin/tazobactam

🔷 Sepsis: fluids, cultures, antibiotics, vasopressors

🩺 Nursing & Collaborative Management

🔷 Treat new neurologic deficits urgently

🔷 Monitor airway, breathing, circulation continuously

🔷 Report fever in chemotherapy patient immediately

🔷 Maintain strict I&O and cardiac monitoring

🔷 Prepare for ICU/oncology emergency transfer

🔷 Educate patients early warning signs at home

2️⃣1️⃣ 🎗️ Tumor Lysis Syndrome

🧬 Pathophysiology & Risk Factors

🔷 Rapid tumor cell breakdown releases intracellular contents

🔷 Potassium ↑, phosphate ↑, uric acid ↑

🔷 Calcium ↓ due phosphate binding

🔷 High-grade lymphoma/leukemia highest risk

🔷 Often occurs after chemotherapy initiation

🔷 Acute kidney injury may develop quickly

🔎 Clinical Manifestations & Diagnostics

🔷 Nausea, vomiting, weakness, muscle cramps

🔷 Dysrhythmias from hyperkalemia life-threatening

🔷 Seizures/tetany from hypocalcemia possible

🔷 Creatinine ↑ indicates renal injury

🔷 Uric acid >8 mg/dL concerning

🔷 ECG changes may show peaked T waves

💊 Medical / Emergency Management

🔷 Aggressive IV hydration protects kidneys

🔷 Allopurinol prevents uric acid formation

🔷 Rasburicase breaks down existing uric acid

🔷 Treat hyperkalemia with insulin + dextrose

🔷 Phosphate binders reduce phosphate absorption

🔷 Dialysis if refractory renal/electrolyte crisis

🩺 Nursing & Collaborative Management

🔷 Monitor electrolytes every 4–6 hours

🔷 Continuous ECG for potassium abnormalities

🔷 Strict I&O, urine output monitoring

🔷 Report muscle twitching or arrhythmias promptly

🔷 Avoid potassium/phosphate-rich supplements

🔷 Collaborate oncology/nephrology for rapid management

2️⃣2️⃣ 🎗️ Spinal Cord Compression

🧬 Pathophysiology & Risk Factors

🔷 Tumor/metastasis compresses spinal cord structures

🔷 Common cancers: breast, lung, prostate, myeloma

🔷 Vertebral metastasis weakens bone stability

🔷 Cord ischemia causes irreversible neurologic loss

🔷 Back pain often precedes neurologic deficits

🔷 Untreated compression may cause paralysis

🔎 Clinical Manifestations & Diagnostics

🔷 New severe back pain warning sign

🔷 Pain worsens lying down/coughing

🔷 Leg weakness, numbness, gait difficulty

🔷 Bladder/bowel dysfunction late serious sign

🔷 MRI spine diagnostic imaging of choice

🔷 Neuro exam tracks motor/sensory changes

💊 Medical / Emergency Management

🔷 Dexamethasone reduces edema and inflammation

🔷 Emergency radiation shrinks sensitive tumors

🔷 Surgical decompression/stabilization selected cases

🔷 Analgesics manage severe back pain

🔷 Treat underlying malignancy systemically

🔷 Immobilization if spinal instability suspected

🩺 Nursing & Collaborative Management

🔷 Treat as oncologic emergency immediately

🔷 Maintain spinal precautions if unstable

🔷 Monitor motor strength and sensation frequently

🔷 Assess urinary retention/incontinence changes

🔷 Prepare for urgent MRI and radiation

🔷 Coordinate oncology/neurosurgery/rehab teams

2️⃣3️⃣ 🎗️ Superior Vena Cava Syndrome

🧬 Pathophysiology & Risk Factors

🔷 Tumor compresses superior vena cava

🔷 Venous return from head/neck/chest impaired

🔷 Common causes: lung cancer, lymphoma

🔷 Increased venous pressure causes swelling/congestion

🔷 Airway/cerebral edema may occur severe cases

🔷 Supine position often worsens symptoms

🔎 Clinical Manifestations & Diagnostics

🔷 Facial/neck swelling and redness

🔷 Jugular venous distention prominent finding

🔷 Dyspnea, cough, hoarseness possible

🔷 Headache, dizziness, visual changes may occur

🔷 Chest CT identifies compression/obstruction

🔷 Biopsy determines underlying malignancy type

💊 Medical / Emergency Management

🔷 Elevate HOB to improve venous drainage

🔷 Oxygen therapy for respiratory distress

🔷 Dexamethasone reduces tumor-related edema

🔷 Radiation/chemotherapy treats sensitive tumors

🔷 Endovascular stent relieves obstruction rapidly

🔷 Diuretics sometimes used cautiously for swelling

🩺 Nursing & Collaborative Management

🔷 Avoid upper extremity IV/BP if severe

🔷 Monitor airway compromise and mental status

🔷 Keep patient upright, avoid flat positioning

🔷 Assess facial swelling and respiratory effort

🔷 Prepare for urgent imaging/intervention

🔷 Provide anxiety reduction and reassurance

2️⃣4️⃣ 🎗️ Hypercalcemia of Malignancy

🧬 Pathophysiology & Risk Factors

🔷 Tumors release PTH-related peptide

🔷 Bone metastases release calcium into blood

🔷 Common cancers: breast, lung, myeloma

🔷 Dehydration worsens serum calcium elevation

🔷 Renal impairment decreases calcium excretion

🔷 Severe hypercalcemia causes neurologic/cardiac toxicity

🔎 Clinical Manifestations & Diagnostics

🔷 “Stones, bones, groans, psychic overtones”

🔷 Confusion, lethargy, weakness common

🔷 Constipation, nausea, abdominal pain occur

🔷 Polyuria, dehydration, excessive thirst present

🔷 Calcium >10.5 mg/dL elevated

🔷 ECG may show shortened QT interval

💊 Medical / Emergency Management

🔷 IV normal saline restores volume/excretion

🔷 Calcitonin lowers calcium rapidly short-term

🔷 Zoledronic acid inhibits bone resorption

🔷 Pamidronate alternative IV bisphosphonate

🔷 Furosemide only after adequate hydration

🔷 Dialysis severe refractory renal failure cases

🩺 Nursing & Collaborative Management

🔷 Monitor calcium, creatinine, ECG trends

🔷 Strict I&O, hydration status assessment

🔷 Implement fall precautions for weakness/confusion

🔷 Encourage mobility if safe to reduce bone loss

🔷 Monitor constipation and bowel function

🔷 Teach symptoms requiring urgent reporting

2️⃣5️⃣ 🎗️ SIADH in Cancer

🧬 Pathophysiology & Risk Factors

🔷 Excess ADH causes water retention

🔷 Dilutional hyponatremia develops gradually/rapidly

🔷 Small-cell lung cancer common cause

🔷 CNS tumors/metastases may trigger SIADH

🔷 Some chemotherapy drugs worsen sodium imbalance

🔷 Severe hyponatremia causes cerebral edema

🔎 Clinical Manifestations & Diagnostics

🔷 Headache, nausea, confusion early symptoms

🔷 Seizures/coma occur severe hyponatremia

🔷 Serum sodium <135 mEq/L

🔷 Serum osmolality ↓ <275 mOsm/kg

🔷 Urine osmolality inappropriately concentrated

🔷 Urine sodium usually elevated >40 mEq/L

💊 Medical / Emergency Management

🔷 Fluid restriction primary management strategy

🔷 Hypertonic saline 3% severe symptomatic cases

🔷 Tolvaptan blocks vasopressin receptor

🔷 Furosemide promotes free-water excretion

🔷 Treat underlying malignancy contributing SIADH

🔷 Correct sodium slowly to prevent demyelination

🩺 Nursing & Collaborative Management

🔷 Monitor neurologic status closely

🔷 Implement seizure precautions if severe

🔷 Strict I&O and daily weights

🔷 Monitor sodium every 4–6 hours if acute

🔷 Educate fluid restriction compliance

🔷 Report sudden confusion/seizures immediately

2️⃣6️⃣ 🎗️ Disseminated Intravascular Coagulation in Cancer

🧬 Pathophysiology & Risk Factors

🔷 Cancer triggers widespread clotting cascade activation

🔷 Microthrombi consume platelets and clotting factors

🔷 Bleeding occurs after factor depletion

🔷 Acute promyelocytic leukemia strongly associated

🔷 Sepsis and advanced malignancy increase risk

🔷 Organ ischemia may develop from microclots

🔎 Clinical Manifestations & Diagnostics

🔷 Bleeding from IV sites, gums, wounds

🔷 Petechiae, ecchymosis, hematuria, melena possible

🔷 Platelets ↓, fibrinogen ↓, D-dimer ↑

🔷 PT/INR ↑ and aPTT ↑ prolonged

🔷 Schistocytes may appear on peripheral smear

🔷 Hypotension suggests shock or major bleeding

💊 Medical / Emergency Management

🔷 Treat underlying malignancy or sepsis trigger

🔷 Platelet transfusion for severe bleeding/thrombocytopenia

🔷 Fresh frozen plasma replaces clotting factors

🔷 Cryoprecipitate replaces fibrinogen if low

🔷 Heparin rarely used in chronic thrombotic DIC

🔷 ICU care if unstable bleeding/shock present

🩺 Nursing & Collaborative Management

🔷 Monitor bleeding sites and skin changes

🔷 Avoid IM injections and unnecessary venipuncture

🔷 Apply pressure after blood draws longer

🔷 Track CBC, PT/INR, aPTT, fibrinogen

🔷 Strict I&O, monitor renal perfusion

🔷 Prepare emergency blood products rapidly

2️⃣7️⃣ 🎗️ Febrile Neutropenia

🧬 Pathophysiology & Risk Factors

🔷 Chemotherapy suppresses neutrophil production

🔷 ANC <500/mm³ = severe infection risk

🔷 Fever may be only infection sign

🔷 Mucositis allows bacterial bloodstream entry

🔷 Central venous catheter increases bacteremia risk

🔷 Delayed antibiotics increase mortality risk

🔎 Clinical Manifestations & Diagnostics

🔷 Single oral temperature ≥38.3°C urgent

🔷 Sustained temperature ≥38.0°C for 1 hour

🔷 ANC <500/mm³ or expected decline

🔷 Chills, malaise, hypotension may occur

🔷 Blood cultures peripheral + central line

🔷 Chest x-ray/urine culture based on symptoms

💊 Medical / Emergency Management

🔷 Cefepime broad-spectrum empiric therapy

🔷 Piperacillin/tazobactam alternative empiric therapy

🔷 Meropenem if resistant organism risk

🔷 Vancomycin if catheter infection/MRSA concern

🔷 Filgrastim may support neutrophil recovery

🔷 Antifungal therapy if persistent fever prolonged neutropenia

🩺 Nursing & Collaborative Management

🔷 Treat fever as emergency, no delay

🔷 Obtain cultures before antibiotics if possible

🔷 Start antibiotics within 60 minutes

🔷 Implement neutropenic precautions strictly

🔷 Avoid fresh flowers, raw foods, sick visitors

🔷 Monitor sepsis signs and lactate trends

2️⃣8️⃣ 🎗️ Increased Intracranial Pressure from Brain Tumor

🧬 Pathophysiology & Risk Factors

🔷 Tumor mass increases intracranial volume

🔷 Cerebral edema worsens pressure effect

🔷 Obstructed CSF flow causes hydrocephalus

🔷 Normal ICP adult 5–15 mmHg

🔷 ICP >20 mmHg concerning sustained elevation

🔷 Herniation risk if pressure untreated

🔎 Clinical Manifestations & Diagnostics

🔷 Morning headache, vomiting, blurred vision

🔷 Seizures may be first tumor manifestation

🔷 Papilledema suggests prolonged ICP elevation

🔷 Personality/cognition changes may occur

🔷 CT/MRI shows mass, edema, midline shift

🔷 Neuro exam tracks focal deficits

💊 Medical / Emergency Management

🔷 Dexamethasone reduces tumor-related cerebral edema

🔷 Mannitol lowers ICP through osmotic diuresis

🔷 Hypertonic saline reduces cerebral swelling

🔷 Levetiracetam controls/prevents seizures if indicated

🔷 Surgery debulks/removes accessible tumor mass

🔷 Radiation/chemotherapy treats tumor progression

🩺 Nursing & Collaborative Management

🔷 Elevate HOB 30°, head midline

🔷 Monitor LOC, pupils, motor response frequently

🔷 Avoid straining, coughing, hip flexion

🔷 Seizure precautions and airway equipment ready

🔷 Monitor sodium/osmolality with hyperosmolar therapy

🔷 Report Cushing triad immediately

2️⃣9️⃣ 🎗️ Cancer-Related Sepsis

🧬 Pathophysiology & Risk Factors

🔷 Immunosuppression increases infection progression risk

🔷 Neutropenia blunts typical inflammatory response

🔷 Central lines and mucositis increase bloodstream infection

🔷 Sepsis causes vasodilation, capillary leak, hypoperfusion

🔷 Septic shock persists despite adequate fluids

🔷 Delay in antibiotics increases mortality

🔎 Clinical Manifestations & Diagnostics

🔷 Fever or hypothermia, tachycardia, tachypnea

🔷 Hypotension, confusion, oliguria indicate hypoperfusion

🔷 Lactate >2 mmol/L concerning tissue hypoxia

🔷 ANC may be critically low

🔷 Blood cultures identify organism/source

🔷 Procalcitonin may support bacterial infection assessment

💊 Medical / Emergency Management

🔷 Broad-spectrum antibiotics within 1 hour

🔷 30 mL/kg crystalloid for hypotension/lactate elevation

🔷 Norepinephrine first-line vasopressor if shock

🔷 Remove infected line if source confirmed

🔷 Antifungal coverage if prolonged neutropenia/persistent fever

🔷 ICU transfer if worsening organ dysfunction

🩺 Nursing & Collaborative Management

🔷 Activate sepsis pathway immediately

🔷 Monitor MAP goal ≥65 mmHg

🔷 Strict I&O, urine output ≥0.5 mL/kg/hr

🔷 Recheck lactate after resuscitation

🔷 Maintain central line asepsis

🔷 Communicate deterioration rapidly using SBAR

3️⃣0️⃣ 🎗️ Malignant Pleural Effusion / Airway Obstruction

🧬 Pathophysiology & Risk Factors

🔷 Tumor blocks lymph drainage → pleural fluid buildup

🔷 Lung, breast, lymphoma common causes

🔷 Effusion compresses lung, ↓ ventilation

🔷 Airway obstruction from tumor mass/edema

🔷 Hypoxemia worsens as lung expansion decreases

🔷 Recurrent effusions common in advanced cancer

🔎 Clinical Manifestations & Diagnostics

🔷 Dyspnea, orthopnea, cough, chest heaviness

🔷 Decreased breath sounds on affected side

🔷 Dullness to percussion over fluid area

🔷 Chest x-ray shows blunted costophrenic angle

🔷 Ultrasound guides thoracentesis safely

🔷 Pleural fluid cytology may show malignant cells

💊 Medical / Surgical Management

🔷 Oxygen therapy for hypoxemia/distress

🔷 Thoracentesis removes fluid and relieves dyspnea

🔷 Indwelling pleural catheter for recurrent effusion

🔷 Pleurodesis prevents recurrent fluid accumulation

🔷 Bronchoscopy/stent may relieve airway obstruction

🔷 Radiation/chemotherapy treats sensitive obstructing tumors

🩺 Nursing & Collaborative Management

🔷 Position high Fowler’s for lung expansion

🔷 Monitor SpO₂, RR, work of breathing

🔷 Assess post-thoracentesis pneumothorax signs

🔷 Record drainage amount/color/character

🔷 Provide anxiety relief during dyspnea episodes

🔷 Coordinate palliative support for recurrent symptoms

3️⃣1️⃣ 🎗️ Brain Cancer

🧬 Pathophysiology & Risk Factors

🔷 Primary brain tumor arises from CNS cells

🔷 Metastatic tumors commonly from lung/breast/melanoma

🔷 Tumor mass ↑ ICP and cerebral edema

🔷 Glioblastoma highly aggressive malignant brain tumor

🔷 Radiation exposure increases selected tumor risk

🔷 Location determines neurologic deficits and symptoms

🔎 Clinical Manifestations & Diagnostics

🔷 Headache worse morning or with coughing

🔷 New-onset seizures may be first sign

🔷 Personality, memory, speech changes possible

🔷 Focal weakness, visual changes, ataxia occur

🔷 MRI brain with contrast best imaging

🔷 Biopsy confirms tumor type and grade

💊 Medical / Surgical Management

🔷 Dexamethasone reduces tumor-related cerebral edema

🔷 Levetiracetam controls seizures if indicated

🔷 Craniotomy removes or debulks tumor

🔷 Radiation therapy treats residual malignant disease

🔷 Temozolomide used for glioblastoma treatment

🔷 Palliative care supports function and comfort

🩺 Nursing & Collaborative Management

🔷 Monitor LOC, pupils, motor strength frequently

🔷 Maintain seizure precautions and airway readiness

🔷 Elevate HOB 30°, head midline

🔷 Avoid straining, coughing, Valsalva maneuvers

🔷 Support cognition, communication, family coping

🔷 Collaborate neurosurgery, oncology, rehab teams

3️⃣2️⃣ 🎗️ Thyroid Cancer

🧬 Pathophysiology & Risk Factors

🔷 Malignant thyroid cells form nodules/mass

🔷 Papillary type most common, good prognosis

🔷 Medullary type associated with MEN syndromes

🔷 Radiation exposure childhood ↑ risk

🔷 Family history increases inherited cancer risk

🔷 Iodine imbalance may affect thyroid disease patterns

🔎 Clinical Manifestations & Diagnostics

🔷 Painless thyroid nodule common presentation

🔷 Hoarseness suggests recurrent laryngeal nerve involvement

🔷 Dysphagia/dyspnea may indicate compression

🔷 Ultrasound assesses nodule size/features

🔷 Fine-needle aspiration biopsy confirms diagnosis

🔷 TSH, calcitonin, thyroglobulin support evaluation

💊 Medical / Surgical Management

🔷 Thyroidectomy main treatment for many cases

🔷 Radioactive iodine treats selected differentiated cancers

🔷 Levothyroxine suppresses TSH after surgery

🔷 Targeted therapy: lenvatinib for advanced disease

🔷 External radiation for unresectable/local disease

🔷 Monitor calcium after thyroidectomy

🩺 Nursing & Collaborative Management

🔷 Assess airway swelling after thyroidectomy

🔷 Keep tracheostomy set/emergency airway available

🔷 Monitor voice quality and hoarseness

🔷 Assess hypocalcemia: tingling, tetany, Chvostek

🔷 Teach lifelong levothyroxine adherence

🔷 Coordinate endocrine/oncology follow-up labs

3️⃣3️⃣ 🎗️ Breast Cancer

🧬 Pathophysiology & Risk Factors

🔷 Malignant growth from breast duct/lobule cells

🔷 Invasive ductal carcinoma most common type

🔷 Risks: female sex, age, BRCA mutation

🔷 Estrogen exposure, nulliparity, obesity increase risk

🔷 Family history of breast/ovarian cancer important

🔷 Metastasis may involve bone, liver, lung, brain

🔎 Clinical Manifestations & Diagnostics

🔷 Painless hard irregular breast lump common

🔷 Skin dimpling, nipple retraction, peau d’orange

🔷 Bloody nipple discharge concerning finding

🔷 Mammography detects suspicious breast lesions

🔷 Core needle biopsy confirms malignancy

🔷 ER/PR/HER2 testing guides therapy

💊 Medical / Surgical Management

🔷 Lumpectomy with radiation breast-conserving option

🔷 Mastectomy removes breast tissue when indicated

🔷 Chemotherapy: doxorubicin, cyclophosphamide, paclitaxel

🔷 Hormonal therapy: tamoxifen, anastrozole

🔷 HER2 therapy: trastuzumab for HER2-positive disease

🔷 Sentinel lymph node biopsy stages nodal spread

🩺 Nursing & Collaborative Management

🔷 Teach breast self-awareness and screening adherence

🔷 Monitor lymphedema after lymph node removal

🔷 Avoid BP/venipuncture affected arm if instructed

🔷 Support body image and sexuality concerns

🔷 Educate chemo/radiation side effects management

🔷 Coordinate oncology, surgery, rehab, support groups

3️⃣4️⃣ 🎗️ Lung Cancer

🧬 Pathophysiology & Risk Factors

🔷 Malignant transformation of bronchial epithelial cells

🔷 Non-small cell lung cancer most common

🔷 Small cell aggressive, early metastasis common

🔷 Smoking strongest major risk factor

🔷 Radon, asbestos, air pollution increase risk

🔷 Chronic lung disease increases vulnerability

🔎 Clinical Manifestations & Diagnostics

🔷 Persistent cough or change in cough pattern

🔷 Hemoptysis, dyspnea, chest pain possible

🔷 Weight loss, fatigue, hoarseness concerning

🔷 Chest CT identifies mass/nodules

🔷 Bronchoscopy with biopsy confirms diagnosis

🔷 PET scan evaluates metastasis/staging

💊 Medical / Surgical Management

🔷 Lobectomy/pneumonectomy for resectable disease

🔷 Chemotherapy: cisplatin-based regimens common

🔷 Radiation therapy for local control/palliation

🔷 Immunotherapy: pembrolizumab selected advanced disease

🔷 Targeted therapy: osimertinib EGFR mutation

🔷 Palliative oxygen/analgesia for advanced symptoms

🩺 Nursing & Collaborative Management

🔷 Assess respiratory status and oxygenation trends

🔷 Encourage smoking cessation and pulmonary hygiene

🔷 Monitor hemoptysis amount and airway risk

🔷 Teach post-thoracic surgery breathing exercises

🔷 Support nutrition, fatigue, symptom control

🔷 Collaborate pulmonology, oncology, palliative care

3️⃣5️⃣ 🎗️ Stomach / Gastric Cancer

🧬 Pathophysiology & Risk Factors

🔷 Malignancy arises from gastric mucosal cells

🔷 Chronic H. pylori infection major risk

🔷 Smoked/salted foods increase gastric cancer risk

🔷 Pernicious anemia and chronic gastritis predispose

🔷 Advanced disease may invade nearby organs

🔷 Metastasis commonly liver/peritoneum/lymph nodes

🔎 Clinical Manifestations & Diagnostics

🔷 Early symptoms vague dyspepsia/epigastric discomfort

🔷 Weight loss, anorexia, early satiety common

🔷 Occult bleeding causes iron-deficiency anemia

🔷 Vomiting may indicate gastric outlet obstruction

🔷 Endoscopy with biopsy confirms diagnosis

🔷 CT abdomen stages local/distant spread

💊 Medical / Surgical Management

🔷 Partial/total gastrectomy if resectable disease

🔷 Chemotherapy: fluorouracil, oxaliplatin, capecitabine

🔷 Trastuzumab for HER2-positive gastric cancer

🔷 Radiation selected combined-treatment cases

🔷 Treat H. pylori with antibiotic regimen

🔷 Nutritional support after gastrectomy essential

🩺 Nursing & Collaborative Management

🔷 Monitor weight, intake, anemia symptoms

🔷 Teach small frequent post-gastrectomy meals

🔷 Monitor dumping syndrome after gastric surgery

🔷 Encourage high-protein high-calorie nutrition

🔷 Provide antiemetic and pain management support

🔷 Coordinate oncology, surgery, dietitian follow-up

3️⃣6️⃣ 🎗️ Liver Cancer / Hepatocellular Carcinoma

🧬 Pathophysiology & Risk Factors

🔷 Malignant tumor arises from hepatocytes

🔷 Chronic hepatitis B/C major risk factor

🔷 Cirrhosis strongly predisposes liver malignancy

🔷 Alcohol-related liver disease increases risk

🔷 Aflatoxin exposure contributes in endemic areas

🔷 Tumor impairs detoxification, clotting, metabolism

🔎 Clinical Manifestations & Diagnostics

🔷 RUQ pain, hepatomegaly, abdominal fullness

🔷 Weight loss, anorexia, fatigue common

🔷 Jaundice and ascites suggest advanced disease

🔷 AFP often ↑, commonly >400 ng/mL suspicious

🔷 Triphasic CT/MRI shows arterial enhancement pattern

🔷 Liver biopsy confirms when imaging inconclusive

💊 Medical / Surgical Management

🔷 Surgical resection if localized and operable

🔷 Liver transplant selected early-stage cirrhosis cases

🔷 Radiofrequency ablation destroys small tumors

🔷 Transarterial chemoembolization controls unresectable tumors

🔷 Sorafenib or lenvatinib systemic targeted therapy

🔷 Antivirals treat HBV/HCV underlying cause

🩺 Nursing & Collaborative Management

🔷 Monitor bleeding risk, PT/INR, platelets

🔷 Assess ascites, edema, daily weight

🔷 Educate avoid alcohol and hepatotoxic drugs

🔷 Encourage hepatitis vaccination and screening contacts

🔷 Monitor encephalopathy: confusion, asterixis, ammonia

🔷 Collaborate hepatology, oncology, transplant team

3️⃣7️⃣ 🎗️ Colon and Rectal Cancer

🧬 Pathophysiology & Risk Factors

🔷 Malignancy often arises from adenomatous polyps

🔷 APC/KRAS mutations drive abnormal mucosal growth

🔷 Age >50, family history ↑ risk

🔷 IBD, low-fiber diet, obesity contribute

🔷 Left-sided tumors often obstruct earlier

🔷 Rectal cancer may require radiation planning

🔎 Clinical Manifestations & Diagnostics

🔷 Change in bowel habits concerning finding

🔷 Occult blood, melena, hematochezia possible

🔷 Iron-deficiency anemia suggests chronic bleeding

🔷 Narrow pencil stools may indicate obstruction

🔷 Colonoscopy with biopsy confirms diagnosis

🔷 CEA used for monitoring recurrence/response

💊 Medical / Surgical Management

🔷 Surgical resection primary curative treatment

🔷 Colectomy may require temporary/permanent colostomy

🔷 Chemotherapy: fluorouracil, leucovorin, oxaliplatin

🔷 Radiation commonly used for rectal cancer

🔷 Targeted therapy: bevacizumab selected advanced cases

🔷 Colonoscopy surveillance prevents/identifies recurrence

🩺 Nursing & Collaborative Management

🔷 Teach bowel prep and colonoscopy importance

🔷 Monitor postoperative bowel function and bleeding

🔷 Provide colostomy care teaching and support

🔷 Encourage high-fiber diet after recovery if allowed

🔷 Assess body image and psychosocial adaptation

🔷 Collaborate oncology, surgery, ostomy nurse

3️⃣8️⃣ 🎗️ Prostate Cancer

🧬 Pathophysiology & Risk Factors

🔷 Malignant growth from prostate gland tissue

🔷 Androgen-sensitive tumor growth common pattern

🔷 Age >50 major risk factor

🔷 Family history and African ancestry ↑ risk

🔷 Metastasis commonly spreads to bone

🔷 Slow-growing early disease often asymptomatic

🔎 Clinical Manifestations & Diagnostics

🔷 Urinary hesitancy, weak stream, nocturia possible

🔷 Bone pain suggests metastatic disease

🔷 PSA elevated, but not cancer-specific

🔷 Digital rectal exam may reveal hard nodule

🔷 Prostate biopsy confirms malignancy

🔷 Gleason score grades tumor aggressiveness

💊 Medical / Surgical Management

🔷 Active surveillance for low-risk localized disease

🔷 Radical prostatectomy removes prostate gland

🔷 Radiation therapy treats localized disease

🔷 Androgen deprivation: leuprolide, degarelix

🔷 Antiandrogen: bicalutamide blocks receptors

🔷 Docetaxel used advanced metastatic disease

🩺 Nursing & Collaborative Management

🔷 Monitor urinary retention and incontinence post-op

🔷 Teach pelvic floor exercises after prostatectomy

🔷 Discuss erectile dysfunction and fertility concerns

🔷 Monitor PSA trends after treatment

🔷 Support decision-making for surveillance vs treatment

🔷 Collaborate urology, oncology, continence specialists

3️⃣9️⃣ 🎗️ Cervical Cancer

🧬 Pathophysiology & Risk Factors

🔷 Persistent high-risk HPV causes cervical dysplasia

🔷 HPV 16/18 strongly linked to malignancy

🔷 Transformation zone commonly develops precancerous changes

🔷 Early sexual exposure/multiple partners ↑ risk

🔷 Smoking and immunosuppression worsen progression risk

🔷 Lack of screening increases invasive cancer rates

🔎 Clinical Manifestations & Diagnostics

🔷 Postcoital bleeding common early warning sign

🔷 Abnormal vaginal discharge or pelvic pain

🔷 Advanced disease may cause hydronephrosis/leg edema

🔷 Pap smear detects abnormal cytology

🔷 HPV DNA testing identifies high-risk strains

🔷 Colposcopy biopsy confirms diagnosis/staging

💊 Medical / Surgical Management

🔷 LEEP/conization treats precancerous early lesions

🔷 Hysterectomy for selected invasive disease

🔷 Cisplatin-based chemoradiation common advanced treatment

🔷 Brachytherapy delivers localized cervical radiation

🔷 HPV vaccine prevents high-risk HPV infection

🔷 Palliative care for advanced symptom burden

🩺 Nursing & Collaborative Management

🔷 Encourage Pap/HPV screening adherence

🔷 Educate HPV vaccination before exposure ideally

🔷 Monitor bleeding, pain, urinary symptoms

🔷 Support sexuality, fertility, body-image concerns

🔷 Teach radiation side effects and skin care

🔷 Collaborate gyne-oncology, radiation, counseling services

4️⃣0️⃣ 🎗️ Endometrial / Uterine Cancer

🧬 Pathophysiology & Risk Factors

🔷 Malignancy arises from uterine endometrial lining

🔷 Unopposed estrogen stimulates endometrial proliferation

🔷 Obesity increases peripheral estrogen production

🔷 PCOS, nulliparity, late menopause ↑ risk

🔷 Tamoxifen therapy may increase endometrial risk

🔷 Often detected early due abnormal bleeding

🔎 Clinical Manifestations & Diagnostics

🔷 Postmenopausal bleeding is classic warning sign

🔷 Abnormal heavy irregular bleeding premenopausal

🔷 Pelvic pain/pressure may occur later

🔷 Transvaginal ultrasound shows thickened endometrium

🔷 Endometrial biopsy confirms malignancy

🔷 CT/MRI evaluates spread if advanced

💊 Medical / Surgical Management

🔷 Total hysterectomy with bilateral salpingo-oophorectomy

🔷 Lymph node assessment for staging

🔷 Radiation therapy for higher-risk disease

🔷 Chemotherapy: carboplatin, paclitaxel advanced cases

🔷 Progestin therapy selected fertility-sparing cases

🔷 Manage anemia from chronic bleeding

🩺 Nursing & Collaborative Management

🔷 Teach report any postmenopausal bleeding immediately

🔷 Monitor postoperative bleeding and infection signs

🔷 Provide hysterectomy recovery teaching

🔷 Support fertility/sexuality concerns sensitively

🔷 Encourage weight management and diabetes control

🔷 Collaborate gyne-oncology and survivorship care

4️⃣1️⃣ 🎗️ Ovarian Cancer

🧬 Pathophysiology & Risk Factors

🔷 Malignancy commonly arises from ovarian epithelial cells

🔷 BRCA1/BRCA2 mutations significantly increase risk

🔷 Family history breast/ovarian cancer important

🔷 Nulliparity and older age increase risk

🔷 Late detection common due vague symptoms

🔷 Peritoneal spread and ascites frequent complications

🔎 Clinical Manifestations & Diagnostics

🔷 Persistent bloating, pelvic pain, early satiety

🔷 Increased abdominal girth or unexplained ascites

🔷 Urinary frequency or bowel pattern changes

🔷 CA-125 may be elevated, not diagnostic alone

🔷 Transvaginal ultrasound identifies adnexal mass

🔷 CT abdomen/pelvis stages metastasis and spread

💊 Medical / Surgical Management

🔷 Debulking surgery reduces visible tumor burden

🔷 Total hysterectomy with bilateral salpingo-oophorectomy common

🔷 Chemotherapy: carboplatin + paclitaxel standard regimen

🔷 PARP inhibitors: olaparib for BRCA-related disease

🔷 Paracentesis relieves symptomatic malignant ascites

🔷 Palliative care supports advanced symptom control

🩺 Nursing & Collaborative Management

🔷 Monitor abdominal girth, weight, respiratory comfort

🔷 Assess appetite, nausea, bowel function changes

🔷 Provide chemotherapy side-effect education and monitoring

🔷 Encourage genetic counseling for family risk

🔷 Support body image and fertility grief

🔷 Collaborate gyne-oncology, genetics, palliative team

4️⃣2️⃣ 🎗️ Pancreatic Cancer

🧬 Pathophysiology & Risk Factors

🔷 Malignancy commonly arises from pancreatic duct cells

🔷 Tumor obstructs bile duct → jaundice

🔷 Smoking, chronic pancreatitis, diabetes increase risk

🔷 Late diagnosis common due deep location

🔷 Early metastasis to liver/peritoneum frequent

🔷 Cachexia and malabsorption worsen nutritional decline

🔎 Clinical Manifestations & Diagnostics

🔷 Painless jaundice suggests pancreatic head tumor

🔷 Dark urine, pale stools, pruritus occur

🔷 Epigastric pain radiates to back

🔷 Weight loss, anorexia, early satiety common

🔷 CA 19-9 supports monitoring, not screening

🔷 CT pancreas protocol / EUS biopsy confirms

💊 Medical / Surgical Management

🔷 Whipple procedure for resectable head tumors

🔷 Chemotherapy: gemcitabine or FOLFIRINOX regimens

🔷 Biliary stent relieves obstructive jaundice

🔷 Pancreatic enzymes: pancrelipase for malabsorption

🔷 Opioids manage severe cancer pain

🔷 Palliative care early due high symptom burden

🩺 Nursing & Collaborative Management

🔷 Monitor jaundice, pruritus, stool color changes

🔷 Assess pain pattern and analgesic response

🔷 Encourage high-calorie meals and enzyme adherence

🔷 Monitor glucose levels, diabetes may worsen

🔷 Provide psychosocial support for poor prognosis

🔷 Collaborate oncology, surgery, nutrition, palliative care

4️⃣3️⃣ 🎗️ Esophageal Cancer

🧬 Pathophysiology & Risk Factors

🔷 Malignancy affects esophageal mucosal lining

🔷 Squamous type linked smoking and alcohol

🔷 Adenocarcinoma linked GERD and Barrett’s esophagus

🔷 Progressive narrowing causes dysphagia and malnutrition

🔷 Chronic reflux causes metaplasia → dysplasia

🔷 Late diagnosis common due delayed symptoms

🔎 Clinical Manifestations & Diagnostics

🔷 Progressive dysphagia solids → liquids

🔷 Unintentional weight loss common

🔷 Odynophagia, regurgitation, hoarseness possible

🔷 Endoscopy with biopsy confirms diagnosis

🔷 Barium swallow shows narrowing/stricture pattern

🔷 CT/PET evaluates local spread/metastasis

💊 Medical / Surgical Management

🔷 Esophagectomy for selected resectable disease

🔷 Chemoradiation common combined treatment approach

🔷 Stent placement relieves obstructive dysphagia

🔷 Enteral feeding supports nutrition if dysphagic

🔷 Proton pump inhibitors treat reflux symptoms

🔷 Palliative radiation reduces bleeding/obstruction

🩺 Nursing & Collaborative Management

🔷 Assess swallowing ability and aspiration risk

🔷 Encourage soft/high-calorie small frequent meals

🔷 Monitor weight, hydration, albumin trends

🔷 Keep HOB elevated after meals

🔷 Teach feeding tube care if indicated

🔷 Collaborate oncology, GI, dietitian, speech therapy

4️⃣4️⃣ 🎗️ Bladder Cancer

🧬 Pathophysiology & Risk Factors

🔷 Malignancy arises from urothelial bladder lining

🔷 Smoking strongest major bladder cancer risk

🔷 Occupational dye/chemical exposure increases risk

🔷 Chronic irritation may contribute malignant change

🔷 Tumors often cause painless bleeding early

🔷 Recurrence common, requires surveillance cystoscopy

🔎 Clinical Manifestations & Diagnostics

🔷 Painless gross hematuria classic presentation

🔷 Dysuria, urgency, frequency may occur

🔷 Urine cytology detects malignant cells sometimes

🔷 Cystoscopy with biopsy confirms diagnosis

🔷 CT urogram evaluates upper tract involvement

🔷 Staging determines muscle-invasive vs superficial disease

💊 Medical / Surgical Management

🔷 TURBT removes superficial bladder tumors

🔷 Intravesical BCG reduces recurrence risk

🔷 Radical cystectomy for muscle-invasive disease

🔷 Chemotherapy: cisplatin-based regimens

🔷 Urinary diversion after cystectomy may be needed

🔷 Immunotherapy selected advanced disease cases

🩺 Nursing & Collaborative Management

🔷 Monitor hematuria, clots, urinary retention

🔷 Teach cystoscopy surveillance importance

🔷 Educate smoking cessation strongly

🔷 Provide ostomy/urostomy care teaching if needed

🔷 Monitor infection signs after instrumentation

🔷 Collaborate urology, oncology, ostomy nurse

4️⃣5️⃣ 🎗️ Kidney / Renal Cell Cancer

🧬 Pathophysiology & Risk Factors

🔷 Malignancy arises from renal tubular epithelial cells

🔷 Clear cell renal carcinoma most common

🔷 Smoking, obesity, hypertension increase risk

🔷 Von Hippel-Lindau mutation associated risk

🔷 Tumor may invade renal vein/IVC

🔷 Often resistant to traditional chemotherapy

🔎 Clinical Manifestations & Diagnostics

🔷 Classic triad: hematuria, flank pain, mass

🔷 Weight loss, fever, anemia possible

🔷 Paraneoplastic erythrocytosis or hypercalcemia may occur

🔷 CT abdomen with contrast identifies renal mass

🔷 Urinalysis may show blood/RBCs

🔷 Biopsy used when diagnosis uncertain

💊 Medical / Surgical Management

🔷 Partial nephrectomy preserves renal tissue when possible

🔷 Radical nephrectomy for larger/invasive tumors

🔷 Targeted therapy: sunitinib, pazopanib

🔷 Immunotherapy: nivolumab, pembrolizumab selected cases

🔷 Ablation for small tumors/high-risk patients

🔷 Manage hypertension and renal function closely

🩺 Nursing & Collaborative Management

🔷 Monitor hematuria and flank pain changes

🔷 Assess renal function creatinine/eGFR trends

🔷 Teach avoid nephrotoxic drugs if reduced kidney function

🔷 Support postoperative breathing/ambulation after nephrectomy

🔷 Monitor BP, bleeding, infection post-op

🔷 Collaborate urology, oncology, nephrology as needed

4️⃣6️⃣ 🎗️ Skin Cancer: Melanoma and Non-Melanoma

🧬 Pathophysiology & Risk Factors

🔷 UV radiation damages skin-cell DNA

🔷 Basal cell carcinoma grows slowly, locally invasive

🔷 Squamous cell carcinoma may metastasize if untreated

🔷 Melanoma arises from melanocytes, highly metastatic

🔷 Fair skin, sunburns, tanning beds increase risk

🔷 Family history and immunosuppression increase susceptibility

🔎 Clinical Manifestations & Diagnostics

🔷 ABCDE: asymmetry, border, color, diameter, evolution

🔷 Nonhealing sore may suggest basal/squamous carcinoma

🔷 Melanoma may appear dark, irregular, changing lesion

🔷 Dermoscopy improves suspicious lesion evaluation

🔷 Excisional biopsy confirms diagnosis and depth

🔷 Breslow thickness predicts melanoma prognosis

💊 Medical / Surgical Management

🔷 Surgical excision primary treatment for localized lesions

🔷 Mohs surgery preserves tissue in selected sites

🔷 Immunotherapy: pembrolizumab, nivolumab for melanoma

🔷 Targeted therapy: vemurafenib for BRAF mutation

🔷 Radiation used for selected advanced/local disease

🔷 Sunscreen SPF ≥30 reduces UV damage

🩺 Nursing & Collaborative Management

🔷 Teach monthly skin self-examination

🔷 Encourage sun protection and avoiding tanning beds

🔷 Monitor surgical site healing and infection

🔷 Reinforce dermatology follow-up for surveillance

🔷 Educate report changing moles immediately

🔷 Support body image after excision/scarring

4️⃣7️⃣ 🎗️ Bone Cancer / Sarcoma

🧬 Pathophysiology & Risk Factors

🔷 Primary bone tumors arise from bone/connective tissue

🔷 Osteosarcoma commonly affects adolescents/young adults

🔷 Ewing sarcoma affects children/adolescents frequently

🔷 Pain from tumor growth and periosteal stretching

🔷 Prior radiation exposure increases sarcoma risk

🔷 Metastasis commonly spreads to lungs

🔎 Clinical Manifestations & Diagnostics

🔷 Persistent localized bone pain, worse at night

🔷 Swelling, tenderness, reduced limb function

🔷 Pathologic fracture may occur through weakened bone

🔷 X-ray may show destructive bone lesion

🔷 MRI defines local tumor extent

🔷 Biopsy confirms histology before definitive surgery

💊 Medical / Surgical Management

🔷 Chemotherapy: doxorubicin, cisplatin, methotrexate

🔷 Limb-salvage surgery removes tumor when possible

🔷 Amputation rare, for extensive unresectable disease

🔷 Radiation useful in Ewing sarcoma selected cases

🔷 Pain control with opioids/NSAIDs as appropriate

🔷 Pulmonary metastasis may require systemic therapy

🩺 Nursing & Collaborative Management

🔷 Assess pain, mobility, neurovascular status

🔷 Support limb-salvage or amputation adjustment

🔷 Monitor chemotherapy toxicities and infection risk

🔷 Encourage PT for mobility and function

🔷 Provide adolescent psychosocial/body-image support

🔷 Collaborate oncology, orthopedics, rehab team

4️⃣8️⃣ 🎗️ Testicular Cancer

🧬 Pathophysiology & Risk Factors

🔷 Germ cell tumor most common testicular malignancy

🔷 Cryptorchidism significantly increases lifetime risk

🔷 Common in males 15–35 years

🔷 Family history increases susceptibility

🔷 Usually highly curable when detected early

🔷 Metastasis may involve retroperitoneal lymph nodes

🔎 Clinical Manifestations & Diagnostics

🔷 Painless testicular lump or swelling classic

🔷 Scrotal heaviness, dull ache may occur

🔷 Gynecomastia possible hormone-producing tumors

🔷 Ultrasound differentiates solid mass from cyst

🔷 AFP, β-hCG, LDH tumor markers assessed

🔷 CT abdomen/chest evaluates metastasis

💊 Medical / Surgical Management

🔷 Radical inguinal orchiectomy primary treatment

🔷 Chemotherapy: bleomycin, etoposide, cisplatin

🔷 Radiation used for selected seminoma cases

🔷 Sperm banking before treatment preserves fertility

🔷 Surveillance option selected low-risk early disease

🔷 Tumor markers monitored for recurrence

🩺 Nursing & Collaborative Management

🔷 Teach monthly testicular self-examination

🔷 Provide fertility and sexuality counseling

🔷 Monitor bleomycin pulmonary toxicity symptoms

🔷 Support body image after orchiectomy

🔷 Educate follow-up marker/imaging schedule

🔷 Collaborate urology, oncology, fertility services

4️⃣9️⃣ 🎗️ Oral and Head-Neck Cancer

🧬 Pathophysiology & Risk Factors

🔷 Malignancy affects oral cavity, pharynx, larynx

🔷 Tobacco and alcohol strongly increase risk

🔷 HPV associated with oropharyngeal cancers

🔷 Chronic irritation and poor oral hygiene contribute

🔷 Tumor may impair airway, speech, swallowing

🔷 Cervical lymph node metastasis common

🔎 Clinical Manifestations & Diagnostics

🔷 Nonhealing mouth ulcer or white/red patch

🔷 Hoarseness, dysphagia, odynophagia may occur

🔷 Neck mass may indicate lymph node spread

🔷 Unexplained bleeding, pain, weight loss possible

🔷 Endoscopy visualizes tumor extent

🔷 Biopsy confirms diagnosis and HPV status

💊 Medical / Surgical Management

🔷 Surgery removes localized tumor when feasible

🔷 Radiation therapy common definitive/adjuvant treatment

🔷 Chemotherapy: cisplatin concurrent with radiation

🔷 Immunotherapy: pembrolizumab selected advanced cases

🔷 Feeding tube may support nutrition during therapy

🔷 Tracheostomy may be needed airway protection

🩺 Nursing & Collaborative Management

🔷 Assess airway, swallowing, aspiration risk

🔷 Provide oral care and mucositis management

🔷 Teach smoking/alcohol cessation importance

🔷 Support communication after laryngeal surgery

🔷 Monitor nutrition, weight, hydration status

🔷 Collaborate ENT, oncology, speech, dietitian

5️⃣0️⃣ 🎗️ Metastatic Cancer Overview

🧬 Pathophysiology & Risk Factors

🔷 Metastasis = spread beyond primary tumor site

🔷 Routes include lymphatic, hematogenous, direct seeding

🔷 Common sites: bone, liver, lung, brain

🔷 Advanced-stage disease often requires systemic therapy

🔷 Tumor burden causes organ dysfunction symptoms

🔷 Prognosis depends biology, spread, treatment response

🔎 Clinical Manifestations & Diagnostics

🔷 Bone metastasis: pain, fractures, hypercalcemia

🔷 Liver metastasis: jaundice, hepatomegaly, ascites

🔷 Lung metastasis: dyspnea, cough, pleural effusion

🔷 Brain metastasis: headache, seizures, deficits

🔷 PET/CT identifies systemic disease burden

🔷 Biopsy may confirm metastatic origin

💊 Medical / Supportive Management

🔷 Systemic chemotherapy treats widespread disease

🔷 Targeted therapy based on mutation profile

🔷 Immunotherapy selected responsive tumor types

🔷 Radiation relieves painful bone/brain lesions

🔷 Bisphosphonates reduce skeletal-related events

🔷 Palliative care improves symptoms and goals alignment

🩺 Nursing & Collaborative Management

🔷 Assess pain, function, nutrition, mood

🔷 Monitor organ-specific complications closely

🔷 Support advance care planning discussions

🔷 Teach urgent signs: weakness, dyspnea, confusion

🔷 Coordinate home care/hospice when appropriate

🔷 Collaborate oncology, palliative, rehab services

5️⃣1️⃣ 🩸 Leukemia Overview

🧬 Pathophysiology & Risk Factors

🔷 Malignant proliferation of abnormal white blood cells

🔷 Bone marrow crowding suppresses normal cell production

🔷 Acute leukemia progresses rapidly with immature blasts

🔷 Chronic leukemia progresses slower with mature cells

🔷 Risk factors: radiation, benzene, prior chemotherapy

🔷 Infection, anemia, bleeding result from marrow failure

🔎 Clinical Manifestations & Diagnostics

🔷 Fatigue, pallor, fever, recurrent infections

🔷 Petechiae, bruising, gum bleeding common

🔷 Bone pain from marrow expansion

🔷 CBC may show ↑ or ↓ WBC

🔷 Peripheral smear may show blast cells

🔷 Bone marrow biopsy confirms diagnosis

💊 Medical / Supportive Management

🔷 Chemotherapy induces remission and controls disease

🔷 Targeted therapy used for mutation-specific leukemia

🔷 Blood transfusions support anemia/thrombocytopenia

🔷 Antibiotics treat infection during neutropenia

🔷 Stem cell transplant possible curative option

🔷 Allopurinol / rasburicase prevent tumor lysis

🩺 Nursing & Collaborative Management

🔷 Monitor fever as urgent infection warning

🔷 Implement neutropenic and bleeding precautions

🔷 Monitor CBC, uric acid, electrolytes

🔷 Provide meticulous oral and skin care

🔷 Educate avoid crowds, raw foods, injury

🔷 Collaborate hematology-oncology transplant team

5️⃣2️⃣ 🩸 Acute Lymphoblastic Leukemia

🧬 Pathophysiology & Risk Factors

🔷 Malignant lymphoid blasts rapidly accumulate marrow

🔷 Most common childhood leukemia type

🔷 Blasts suppress RBC, platelet, neutrophil production

🔷 CNS and testicular sanctuary sites possible

🔷 Down syndrome increases leukemia susceptibility

🔷 Untreated ALL rapidly fatal disease

🔎 Clinical Manifestations & Diagnostics

🔷 Fever, fatigue, pallor, bruising, infections

🔷 Bone/joint pain common in children

🔷 Lymphadenopathy, hepatosplenomegaly may occur

🔷 CBC: anemia, thrombocytopenia, blasts possible

🔷 Bone marrow blasts ≥20% diagnostic

🔷 Lumbar puncture checks CNS involvement

💊 Medical / Supportive Management

🔷 Multi-agent chemotherapy induction/consolidation/maintenance phases

🔷 Vincristine, prednisone, asparaginase commonly used

🔷 Methotrexate intrathecal for CNS prophylaxis

🔷 Imatinib for Philadelphia chromosome positive cases

🔷 Blood products and antimicrobials supportive care

🔷 Stem cell transplant high-risk/refractory disease

🩺 Nursing & Collaborative Management

🔷 Monitor infection, bleeding, anemia closely

🔷 Support child/family through prolonged treatment

🔷 Maintain central line infection prevention

🔷 Monitor neurotoxicity from vincristine therapy

🔷 Teach medication adherence during maintenance phase

🔷 Coordinate school, psychosocial, nutrition support

5️⃣3️⃣ 🩸 Acute Myeloid Leukemia

🧬 Pathophysiology & Risk Factors

🔷 Malignant myeloid blasts accumulate rapidly

🔷 Common acute leukemia in adults

🔷 Bone marrow failure causes pancytopenia

🔷 Auer rods may appear in myeloblasts

🔷 Prior chemo/radiation and benzene increase risk

🔷 Acute promyelocytic subtype strongly linked DIC

🔎 Clinical Manifestations & Diagnostics

🔷 Fever, weakness, pallor, infections common

🔷 Easy bruising, petechiae, mucosal bleeding

🔷 Gum hypertrophy may occur in some subtypes

🔷 CBC shows anemia/thrombocytopenia/blasts

🔷 Bone marrow blasts ≥20% diagnostic

🔷 Cytogenetics guide prognosis and therapy

💊 Medical / Supportive Management

🔷 Induction chemotherapy often cytarabine + daunorubicin

🔷 Consolidation therapy prevents relapse

🔷 ATRA treats acute promyelocytic leukemia

🔷 Arsenic trioxide used in APL treatment

🔷 Transfusions, antibiotics, antifungals supportive care

🔷 Stem cell transplant selected high-risk AML

🩺 Nursing & Collaborative Management

🔷 Monitor for febrile neutropenia emergency

🔷 Watch DIC signs in APL patients

🔷 Implement bleeding and infection precautions

🔷 Monitor tumor lysis labs frequently

🔷 Provide oral care for mucositis prevention

🔷 Collaborate hematology, blood bank, ICU PRN

5️⃣4️⃣ 🩸 Chronic Lymphocytic Leukemia

🧬 Pathophysiology & Risk Factors

🔷 Clonal mature B lymphocytes accumulate slowly

🔷 Most common adult leukemia in older adults

🔷 Immune dysfunction increases infection risk

🔷 Often indolent and diagnosed incidentally

🔷 Family history may increase susceptibility

🔷 Disease may transform into aggressive lymphoma

🔎 Clinical Manifestations & Diagnostics

🔷 Often asymptomatic with lymphocytosis on CBC

🔷 Painless lymphadenopathy common finding

🔷 Fatigue, night sweats, weight loss possible

🔷 Recurrent infections from immune dysfunction

🔷 Flow cytometry confirms clonal B cells

🔷 Smudge cells seen on peripheral smear

💊 Medical / Supportive Management

🔷 Watchful waiting for asymptomatic early disease

🔷 Ibrutinib targets BTK signaling pathway

🔷 Venetoclax promotes apoptosis in CLL cells

🔷 Rituximab targets CD20-positive B cells

🔷 IVIG may reduce recurrent severe infections

🔷 Treat autoimmune hemolytic anemia if present

🩺 Nursing & Collaborative Management

🔷 Explain observation does not mean neglect

🔷 Monitor infections, lymph nodes, B symptoms

🔷 Teach report fever and night sweats

🔷 Review vaccine timing with provider

🔷 Monitor therapy-related diarrhea, bleeding, arrhythmias

🔷 Collaborate hematology for surveillance schedule

5️⃣5️⃣ 🩸 Chronic Myeloid Leukemia

🧬 Pathophysiology & Risk Factors

🔷 Myeloid cell overproduction from BCR-ABL fusion

🔷 Philadelphia chromosome t(9;22) hallmark abnormality

🔷 Tyrosine kinase activation drives uncontrolled proliferation

🔷 Chronic phase may progress to blast crisis

🔷 Risk factors include radiation exposure

🔷 Splenomegaly from extramedullary hematopoiesis common

🔎 Clinical Manifestations & Diagnostics

🔷 Fatigue, weight loss, night sweats possible

🔷 Left upper quadrant fullness from splenomegaly

🔷 CBC shows marked leukocytosis often very high

🔷 Basophilia may support CML pattern

🔷 BCR-ABL testing confirms diagnosis

🔷 Bone marrow exam supports staging/prognosis

💊 Medical / Supportive Management

🔷 Imatinib first-generation tyrosine kinase inhibitor

🔷 Dasatinib or nilotinib alternative TKI options

🔷 Hydroxyurea may reduce extreme leukocytosis initially

🔷 Allopurinol prevents hyperuricemia/tumor lysis

🔷 Stem cell transplant rare selected resistant cases

🔷 Molecular monitoring tracks BCR-ABL response

🩺 Nursing & Collaborative Management

🔷 Teach strict daily TKI adherence

🔷 Monitor CBC and liver function trends

🔷 Assess edema, diarrhea, rash, fatigue

🔷 Educate avoid missed doses/resistance risk

🔷 Monitor spleen discomfort and early satiety

🔷 Coordinate hematology follow-up molecular testing

5️⃣6️⃣ 🩸 Hodgkin Lymphoma

🧬 Pathophysiology & Risk Factors

🔷 Malignant lymphoma involving Reed-Sternberg cells

🔷 Usually spreads orderly lymph node to node

🔷 EBV infection associated with some cases

🔷 Bimodal age pattern, young adults/older adults

🔷 Immunosuppression increases lymphoma risk

🔷 Highly curable with appropriate therapy

🔎 Clinical Manifestations & Diagnostics

🔷 Painless cervical lymphadenopathy common presentation

🔷 B symptoms: fever, night sweats, weight loss

🔷 Pruritus and alcohol-induced node pain possible

🔷 Excisional lymph node biopsy confirms diagnosis

🔷 Reed-Sternberg cells are pathognomonic finding

🔷 PET/CT used for staging and response

💊 Medical / Supportive Management

🔷 ABVD regimen: doxorubicin, bleomycin, vinblastine, dacarbazine

🔷 Radiation therapy used in selected localized disease

🔷 Brentuximab vedotin used in selected cases

🔷 Check pulmonary function with bleomycin exposure

🔷 Antiemetics reduce chemotherapy-related nausea

🔷 Stem cell transplant relapsed/refractory disease option

🩺 Nursing & Collaborative Management

🔷 Monitor fever, infection, B symptoms progression

🔷 Assess respiratory symptoms during bleomycin therapy

🔷 Provide fertility preservation counseling before treatment

🔷 Educate chemotherapy schedule and side effects

🔷 Monitor CBC for neutropenia/anemia/thrombocytopenia

🔷 Coordinate oncology, fertility, psychosocial support

5️⃣7️⃣ 🩸 Non-Hodgkin Lymphoma

🧬 Pathophysiology & Risk Factors

🔷 Malignant proliferation of lymphocytes, usually B-cells

🔷 Spread often noncontiguous and extranodal

🔷 HIV, immunosuppression, autoimmune disease increase risk

🔷 Some types indolent, others aggressive

🔷 EBV, HTLV-1, H. pylori linked subtypes

🔷 Bone marrow involvement may cause cytopenias

🔎 Clinical Manifestations & Diagnostics

🔷 Painless lymphadenopathy, generalized or localized

🔷 B symptoms may indicate aggressive disease

🔷 Abdominal fullness from splenomegaly/lymph nodes

🔷 Excisional biopsy confirms lymphoma subtype

🔷 Flow cytometry identifies B/T-cell markers

🔷 PET/CT and bone marrow biopsy stage disease

💊 Medical / Supportive Management

🔷 R-CHOP common regimen for diffuse large B-cell lymphoma

🔷 Rituximab targets CD20-positive B-cell tumors

🔷 Radiation used for selected localized disease

🔷 Intrathecal methotrexate for CNS prophylaxis selected cases

🔷 Antibiotic/antiviral prophylaxis for immunosuppressed patients

🔷 CAR-T therapy selected relapsed/refractory lymphoma

🩺 Nursing & Collaborative Management

🔷 Monitor tumor lysis risk with bulky disease

🔷 Assess airway compromise from neck/mediastinal masses

🔷 Implement infection precautions during neutropenia

🔷 Educate report fever, dyspnea, rapid swelling

🔷 Monitor infusion reactions with rituximab

🔷 Coordinate hematology-oncology and supportive care

5️⃣8️⃣ 🩸 Multiple Myeloma

🧬 Pathophysiology & Risk Factors

🔷 Malignant plasma cells overproduce monoclonal protein

🔷 Bone marrow infiltration suppresses normal hematopoiesis

🔷 Osteolytic lesions cause fractures and bone pain

🔷 Light chains damage kidneys, causing renal failure

🔷 Older adults most commonly affected population

🔷 Hypercalcemia from bone destruction may occur

🔎 Clinical Manifestations & Diagnostics

🔷 CRAB findings: calcium ↑, renal failure, anemia, bone lesions

🔷 Bone pain, especially back/ribs, common

🔷 Recurrent infections due low normal antibodies

🔷 Serum protein electrophoresis shows M-spike

🔷 Urine may show Bence Jones proteins

🔷 Skeletal survey/CT/MRI shows lytic lesions

💊 Medical / Supportive Management

🔷 Bortezomib, lenalidomide, dexamethasone common regimen

🔷 Bisphosphonates: zoledronic acid reduce bone events

🔷 Hydration supports renal protection

🔷 Autologous stem cell transplant eligible patients

🔷 Analgesics manage bone pain

🔷 Treat hypercalcemia with saline/calcitonin/bisphosphonates

🩺 Nursing & Collaborative Management

🔷 Monitor creatinine, calcium, CBC trends

🔷 Implement fall precautions due fracture risk

🔷 Encourage hydration unless contraindicated

🔷 Avoid heavy lifting, twisting, injury

🔷 Monitor infection signs and vaccination needs

🔷 Coordinate hematology, nephrology, pain management

5️⃣9️⃣ 🩸 Bone Marrow / Stem Cell Transplant

🧬 Pathophysiology & Risk Factors

🔷 Transplant replaces diseased or destroyed marrow

🔷 Autologous uses patient’s own stem cells

🔷 Allogeneic uses donor stem cells

🔷 Conditioning chemotherapy/radiation causes profound immunosuppression

🔷 Engraftment restores neutrophil and platelet production

🔷 Complications include infection, rejection, GVHD

🔎 Clinical Manifestations & Diagnostics

🔷 Pancytopenia expected after conditioning regimen

🔷 ANC recovery signals engraftment progress

🔷 Fever during neutropenia is emergency

🔷 Mucositis, diarrhea, fatigue common toxicities

🔷 Chimerism testing assesses donor cell engraftment

🔷 Monitor liver, renal, pulmonary function closely

💊 Medical / Supportive Management

🔷 Conditioning regimens include high-dose chemotherapy

🔷 Filgrastim may support neutrophil recovery

🔷 Antimicrobial prophylaxis prevents opportunistic infections

🔷 Immunosuppressants: cyclosporine, tacrolimus prevent GVHD

🔷 Blood product support during pancytopenia

🔷 Total parenteral nutrition sometimes needed severe mucositis

🩺 Nursing & Collaborative Management

🔷 Protective isolation during severe neutropenia

🔷 Strict hand hygiene and central-line care

🔷 Monitor fever, bleeding, mucositis, diarrhea

🔷 Teach food safety and infection avoidance

🔷 Provide emotional support during prolonged isolation

🔷 Coordinate transplant team, dietitian, psychosocial services

6️⃣0️⃣ 🩸 Graft-versus-Host Disease

🧬 Pathophysiology & Risk Factors

🔷 Donor immune cells attack recipient tissues

🔷 Occurs after allogeneic stem cell transplant

🔷 Acute GVHD commonly affects skin, liver, gut

🔷 Chronic GVHD may affect many organs

🔷 HLA mismatch increases GVHD risk

🔷 Immunosuppression withdrawal may trigger flare

🔎 Clinical Manifestations & Diagnostics

🔷 Skin rash, erythema, peeling common early

🔷 Diarrhea, abdominal cramping indicate GI involvement

🔷 Jaundice, bilirubin ↑ suggest liver involvement

🔷 Chronic dry eyes/mouth and skin tightening possible

🔷 Biopsy may confirm affected organ involvement

🔷 Monitor LFTs, stool volume, skin changes

💊 Medical / Supportive Management

🔷 Corticosteroids: prednisone, methylprednisolone first-line

🔷 Tacrolimus or cyclosporine used for prevention/treatment

🔷 Ruxolitinib selected steroid-refractory GVHD

🔷 Antidiarrheals and nutrition support for GI disease

🔷 Infection prophylaxis during immunosuppression

🔷 Topical steroids for limited skin involvement

🩺 Nursing & Collaborative Management

🔷 Monitor rash progression and skin integrity

🔷 Measure stool output accurately every shift

🔷 Assess jaundice, pruritus, liver enzyme trends

🔷 Maintain infection precautions during immunosuppression

🔷 Educate report diarrhea/rash immediately

🔷 Coordinate transplant provider urgently for flare symptoms

Oncology nursing requires strong clinical judgment across prevention, screening, diagnosis, treatment, complications, survivorship, and palliative care. Nurses must recognize oncologic emergencies early, monitor chemotherapy/radiation/immunotherapy toxicities, protect immunocompromised patients, and support complex psychosocial needs. Effective cancer care integrates evidence-based treatment, symptom control, patient education, infection prevention, nutrition, rehabilitation, and interdisciplinary coordination. Mastery of oncology nursing strengthens patient safety, treatment adherence, quality of life, and holistic care across the full cancer continuum.